C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,580,232 | -31.5% | 1,924,856 | +1.3% | 0.00% | – |
| Q2 2023 | $5,225,979 | -21.2% | 1,900,356 | -10.0% | 0.00% | – |
| Q1 2023 | $6,633,331 | -45.6% | 2,112,526 | +2.3% | 0.00% | – |
| Q4 2022 | $12,182,998 | -31.2% | 2,064,915 | +2.2% | 0.00% | -100.0% |
| Q3 2022 | $17,711,000 | +19.8% | 2,019,654 | +3.0% | 0.00% | – |
| Q2 2022 | $14,783,000 | -69.9% | 1,960,713 | -3.0% | 0.00% | -100.0% |
| Q1 2022 | $49,057,000 | -24.4% | 2,022,142 | +0.3% | 0.00% | 0.0% |
| Q4 2021 | $64,929,000 | -25.0% | 2,016,459 | +4.0% | 0.00% | -50.0% |
| Q3 2021 | $86,616,000 | +62.7% | 1,938,575 | +37.8% | 0.00% | +100.0% |
| Q2 2021 | $53,234,000 | +270.9% | 1,406,840 | +262.6% | 0.00% | – |
| Q1 2021 | $14,351,000 | -4.2% | 387,958 | -14.2% | 0.00% | – |
| Q4 2020 | $14,980,000 | – | 452,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |